Last week, it was announced that the UK had invested £45 million to fight malaria in Uganda. The country still suffers from the malaria burden and so ending the disease will not only save people’s lives but will also drive economic growth, increasing income per capita.
Joining me today is Rob Mather, the CEO of the Against Malaria Foundation. The foundation funds anti-malaria nets, specifically long-lasting insecticidal nets, LLINs.
CRISPR is a form of gene editing that has revolutionised the field of genetics. Previously, creating genetically modified organisms took a considerable amount of time and money. CRISPR has changed that, with the potential to change the way we look at medicine.
Access to healthcare can be extremely limited, with the nearest health facility located hours away. Transaid is using bicycle ambulances to transport mothers and children.
We have observed the redistribution of mosquito populations responsible for infectious diseases, they’ve undergone epidemiological changes.